Shows
IJGC conversationsNeoadjuvant Chemotherapy: Mortality in Low- vs High-Volume CentersIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alex Melamed to discuss Neoadjuvant Chemotherapy: Mortality in Low- vs High-Volume Centers.
Alex Melamed, MD, MPH, is a gynecologic oncologist and clinical outcomes researcher in the Department of Obstetrics and Gynecology at Mass General Hospital and an Associate Professor at Harvard Medical School. He co-directs the Inference Lab in MGH's Vincent Department of Obstetrics and Gynecology. Dr. Melamed's research focuses on applying methods that provide meaningful insights from observational data. In particular, his work explores how focusing on temporal and spatial...
2026-02-0942 min
IJGC conversationsMirvetuximab in Low-Grade Ovarian Cancer with Alessandro D. SantinIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alessandro D. Santin to discuss Mirvetuximab in Low-Grade Ovarian Cancer.
Dr. Alessandro D. Santin, a native of Italy, graduated with honors from the University of Brescia, Italy and received his postgraduate training in Obstetrics & Gynecology at the same University. He served a fellowship in Gynecologic Oncology at the University of California, Irvine and an International Fellowship in the Division of Gynecologic Oncology at the University of Arkansas for Medical Sciences, Little Rock, Arkansas. Dr. Santin joined the faculty in the S...
2026-02-0239 min
IJGC conversationsICG Angiography for Bowel Anastomosis Evaluation with Stephanie GillIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Stephanie Gill to discuss ICG Angiography for Bowel Anastomosis Evaluation.
Stephanie J. Gill, MD, FRCSC, MSc, MScHSE, is a second-year Gynecologic Oncology Fellow at the University of Toronto in Toronto, Canada, with clinical appointments at Princess Margaret Cancer Centre and the Odette Cancer Centre. She holds two Master’s degrees in Medical Sciences—focused on biostatistics and epidemiology—and Health Sciences Education, with a particular interest in robotic surgery training and competency-based assessment. Her research interests include surgical innovation and enhance...
2026-01-2638 min
IJGC conversationsESMO 2025 Highlights: Top Studies In Gynecologic Oncology with Mariana ScarantiIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Mariana Scaranti to discuss ESMO 2025 Highlights: Top Studies In Gynecologic Oncology.
Mariana Scaranti, MD, is a Brazilian medical oncologist dedicated to gynecologic oncology. She practices at Hospital 9 de Julho in São Paulo and is the National Lead for Gynecologic Oncology at Rede Américas, Brazil. She serves as Research Director of Grupo EVA, the Brazilian Gynecologic Oncology Group, and is a member of the Gynecologic Tumors Committee of the Brazilian Society of Clinical Oncology (SBOC). She previously trained as a f...
2026-01-1933 min
IJGC conversationsESGO-ESTRO-ESP 2025 Endometrial Cancer Guidelines with Nicole ConcinIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss ESGO-ESTRO-ESP 2025 Endometrial Cancer Guidelines.
Professor Concin serves as the Chair of the Department of Gynaecology and Gynaecological Oncology and as Director of the Department of Obstetrics and Gynaecology at the Medical University of Vienna. She is President of the Austrian Network of Gynaecologic Oncology (AGO Austria), Executive Committee member of
the European Society of Gynaecological Oncology (ESGO), immediate Past-President of the ESGO, Board of Directors member of GCIG Gynaecologic Cancer InterGroup (GCIG), education faculty member f...
2026-01-1246 min
IJGC conversationsctDNA & diagnosis of ovarian cancer with Cristina Taliento and Giuseppe VizzielliIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Cristina Taliento and Giuseppe Vizzielli to discuss ctDNA & diagnosis of ovarian cancer.
Cristina Taliento is a gynecologist and PhD candidate in a joint PhD program at the University Hospital of Ferrara, Italy, and KU Leuven, Belgium, associated with the International Ovarian Tumour Analysis (IOTA) Group. She completed a Research Fellowship at the European Institute of Oncology in Milan. She recently started her Fellowship Training in Gynecologic Oncology at the University Hospital of Heidelberg, Germany. Her PhD research focuses on clinical a...
2026-01-0538 min
IJGC conversationsIJGC conversations 2025 December Editor's Choice
In this episode of the IJGC conversations 2025 December Editor's Choice, Editorial Fellow Itziar Villagrá, Joannie Neveu, and Mathilde Del discusses the contents of the 2025 December issue of IJGC.
2025-12-3012 min
IJGC conversationsRevisited: ctDNA: Results from CALLA Trial with Bradley Monk
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Bradley Monk to discuss ctDNA: Results from CALLA Trial.
Bradley Monk, MD, FACOG, FACS is a board-certified gynecologic oncologist with Florida Cancer Specialists & Research Institute and medical director of the Late-Stage Clinical Research Program. He provides care to patients at the FCS West Palm Beach location.
Dr. Monk has extensive leadership experience in practice-changing clinical research and the development of clinical research programs in community oncology settings. His research special interests are primarily focused on the prevention and treatment o...
2025-12-2936 minIJGC conversationsRevisited: RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham
In this IJGC podcast, Dr. Pedro Ramirez discusses RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham.
Prof Susana Banerjee MBBS MA PhD FRCP is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London. She is also Professor in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers. Prof Banerjee is President of the Royal Society of Medicine Oncology Section.
Prof Ban...
2025-12-2242 min
IJGC conversationsRevisited: SENTIX Trial with David Cibula
In this IJGC podcast, Dr. Pedro Ramirez discusses SENTIX Trial with David Cibula.
Dr. David Cibula graduated from the First Faculty of Medicine at Charles University in Prague in 1992. Since 2003, he has served as the Chair of the Gynecological Oncology Center at the University Hospital in Prague, and in 2022, he became the head of the Department of Gynecology, Obstetrics, and Neonatology.
He is a former President of the European Society of Gynecologic Oncology and previously led the International Group for Guidelines and Quality Indicators in Cervical Cancer. He is the founder and chair of the...
2025-12-1550 min
IJGC conversationsRevisited: ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy with Frédéric Amant
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.
Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his thesis on uterine sarcomas in 2002 at the KU Leuven. He is specialist at the UZ Leuven in Belgium. He is professor at the KU Leuven in Belgium and at th...
2025-12-0840 min
IJGC conversationsSUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis ChivaIn this IJGC podcast, Dr. Pedro Ramirez discusses SUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis Chiva.
Prof. Luis M. Chiva, MD, PhD, is Chair of Obstetrics and Gynecology and Professor of Gynecology and Medical Ethics at the University of Navarra in Pamplona, Spain. An internationally recognized leader in gynecologic oncology, he is renowned for his expertise in complex pelvic oncologic surgery and his commitment to advancing surgical quality and patient-centered care.
A graduate of the University of Madrid, Dr. Chiva completed his gynecologic oncology fellowship at Rush-Presbyterian–St. Luke’s Med...
2025-12-0139 min
IJGC conversationsUpdates in Radiotherapy in Gynecologic Cancers with Junzo ChinoIn this IJGC podcast, Dr. Pedro Ramirez discusses Updates in Radiotherapy in Gynecologic Cancers with Junzo Chino.
Dr. Chino is an Associate Professor of Radiation Oncology and Director of Brachytherapy at the Duke Cancer Center. He has authored over 100 publications in the peer reviewed literature, and his research interests are concentrated in radiation therapy for gynecologic cancer, as well as health services and disparities. He was lead author of the ASTRO guidelines task force for cervical cancer, and served as the GYN section editor at the International Journal of Radiation Oncology Biology and Physics and Ass...
2025-11-2438 minIJGC conversationsIJGC conversations 2025 November Editor's Choice
In this episode of the IJGC conversations 2025 November Editor's Choice, Editorial Fellow Paula Mateo-Kubach and Matteo Loverro discusses the contents of the 2025 November issue of IJGC.
2025-11-2214 min
IJGC conversationsResults of the MoST-CIRCUIT Trial with Oliver KleinIn this IJGC podcast, Dr. Pedro Ramirez discusses Results of the MoST-CIRCUIT Trial with Oliver Klein.
A/Prof Klein is a clinician-scientist at the Austin Hospital and the ONJCRI with a 20-year experience in the field of cancer immunotherapy and a particular interest in the treatment of rare gynaecological malignancies. Dr Klein pioneered clinical trials using checkpoint blockade in patients with advanced rare cancers including gynaecological malignancies. These trials demonstrated unprecedented clinical outcomes in this patient population of major unmet medical need. Next to his clinical research, Dr Klein participates and leads translational research investigating b...
2025-11-1736 minIJGC conversationsAddition of Metronidazole to Prevent SSI with Megan Gorman and Marina FrimerIn this IJGC podcast, Dr. Pedro Ramirez discusses Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer.
Dr. Marina Frimer is a gynecologic oncologist and physician-scientist whose work bridges clinical innovation and translational research in gynecologic malignancies. As Associate Professor at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief for Research and Academic Development at Northwell Health, she plays a key role in advancing academic and clinical research programs in women’s cancer.
Dr. Frimer’s research focuses on improving surgical and therapeutic outcomes in gynecologic oncology, with...
2025-11-1231 minIJGC conversationsCheckpoint Inhibitor Rechallenge in Endometrial Cancer with Brian SlomovitzIn this IJGC podcast, Dr. Pedro Ramirez discusses Checkpoint Inhibitor Rechallenge in Endometrial Cancer with Brian Slomovitz.
Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies.
2025-11-0329 minIJGC conversationsPEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca KristeleitIn this IJGC podcast, Dr. Pedro Ramirez discusses PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit.
Rebecca Kristeleit is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust and an Adjunct Associate Professor in the Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences at KCL, London. She is Research Lead for gynaecological cancer, R&D Lead for Oncology and Clinical Lead for Oncology and Haematology Clinical Trials at Guy’s and St Thomas’ NHS Foundation Trust. She works as a Principle Investigator within the KCL Cancer Early Phase Trials Un...
2025-10-2737 minIJGC conversationsADCs and Oral Mucositis with Michelle D.S. LightfootIn this IJGC podcast, Dr. Pedro Ramirez discusses ADCs and Oral Mucositis: Strategies for Gynecologic Oncologists with Michelle D. Lightfoot.
Michelle D. Lightfoot, MD, joined NYU Langone in August 2021 after completing fellowship training in gynecologic oncology at The Ohio State University. She received her medical degree from Harvard Medical School and a master’s in public health from Columbia University’s Mailman School of Public Health, before completing residency training at Beth Israel Deaconess Medical Center/Harvard Medical School.
At NYU Langone’s Perlmutter Cancer Center and Bellevue Hospital, Dr. Lightfoot provides clinical care an...
2025-10-2030 minIJGC conversationsIJGC conversations 2025 October Editor's Choice
In this episode of the IJGC conversations 2025 October Editor's Choice, Editorial Fellow Tommaso Meschini and Carlotta Sabini discusses the contents of the 2025 October issue of IJGC.
2025-10-1413 minIJGC conversationsROSELLA Trial: Relacorilant in Platinum-resistant Ovarian Cancer with Alexander B. OlawaiyeIn this IJGC podcast, Dr. Pedro Ramirez discusses ROSELLA Trial: Relacorilant in Platinum-resistant Ovarian Cancer with Alexander B. Olawaiye.
Dr. Olawaiye a Professor and Vice Chair for DI at the Department of Obstetrics, Gynecology and Reproductive Sciences. He is director of gynecologic cancer research at Magee-Women’s Hospital of the University of Pittsburgh Medical Center, and has overseen multiple clinical research projects. He is also the Gynecologic Oncology Group Foundation principal investigator for the University of Pittsburgh Cancer Institute and in this role has collaborated with multiple clinical scientists across the country to conduct phases I, II and...
2025-10-1343 minIJGC conversationsCarcinosarcoma with no myoinvasion with Giuseppe Cucinella and Mario M. Leitao, Jr.In this IJGC podcast, Dr. Pedro Ramirez discusses Carcinosarcoma with no myoinvasion with Giuseppe Cucinella and Mario M. Leitao, Jr.
Giuseppe Cucinella, MD, is a gynecologist working at Istituto Nazionale Tumori IRCSS Fondazione G.Pascale in Naples, Italy (Department of Gynecologic Oncology). During his residency, he worked as a research fellow at Mayo Clinic in Rochester, Minnesota, where he focused on the study of endometrial cancer. He is currently in the second year of the PhD program in "Experimental Oncology and Surgery - Gynecologic Oncology" at the University of Palermo, Palermo (Italy). Dr. Cucinella's clinical research focuses on t...
2025-10-0638 minIJGC conversationsIJGC conversations 2025 September Editor's Choice
In this episode of the IJGC conversations 2025 September Editor's Choice, Editorial Fellow Filippo Capomacchia and Natalia Teixeira discusses the contents of the 2025 September issue of IJGC.
2025-09-3020 minIJGC conversationsSENTIX Trial with David CibulaIn this IJGC podcast, Dr. Pedro Ramirez discusses SENTIX Trial with David Cibula.
Dr. David Cibula graduated from the First Faculty of Medicine at Charles University in Prague in 1992. Since 2003, he has served as the Chair of the Gynecological Oncology Center at the University Hospital in Prague, and in 2022, he became the head of the Department of Gynecology, Obstetrics, and Neonatology.
He is a former President of the European Society of Gynecologic Oncology and previously led the International Group for Guidelines and Quality Indicators in Cervical Cancer. He is the founder and chair of the...
2025-09-2950 minIJGC conversationsRAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. GrishamIn this IJGC podcast, Dr. Pedro Ramirez discusses RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham.
Prof Susana Banerjee MBBS MA PhD FRCP is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London. She is also Professor in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers. Prof Banerjee is President of the Royal Society of Medicine Oncology Section.
Prof Ban...
2025-09-2242 minIJGC conversationsSurgical Approach in Recurrent Granulosa Cell Tumor with Tyler Hillman and Allison Lynn BrodskyIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Tyler Hillman and Allison Lynn Brodsky to discuss Surgical Approach in Recurrent Granulosa Cell Tumor.
Tyler Hillman, MD, PhD, is a board-certified gynecologic oncologist at UC San Diego Health, where he specializes in medical and surgical management of gynecologic cancers, with expertise in minimally invasive surgery, symptom management, and novel therapies. An associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, he teaches medical students, residents, and fellows at UC San Diego School of Medicine.
Dr. Hillman’s r...
2025-09-1525 minIJGC conversationsctDNA: Results from CALLA Trial with Bradley MonkIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Bradley Monk to discuss ctDNA: Results from CALLA Trial.
Bradley Monk, MD, FACOG, FACS is a board-certified gynecologic oncologist with Florida Cancer Specialists & Research Institute and medical director of the Late-Stage Clinical Research Program. He provides care to patients at the FCS West Palm Beach location.
Dr. Monk has extensive leadership experience in practice-changing clinical research and the development of clinical research programs in community oncology settings. His research special interests are primarily focused on the prevention and treatment o...
2025-09-0836 minIJGC conversationsESGO/INCIP 2025 Guidelines for Cancer in Pregnancy with Frédéric AmantIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.
Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his thesis on uterine sarcomas in 2002 at the KU Leuven. He is specialist at the UZ Leuven in Belgium. He is professor at the KU Leuven in Belgium and at th...
2025-09-0140 minIJGC conversationsIJGC conversations 2025 August Editor's ChoiceIn this episode of the IJGC conversations 2025 August Editor's Choice, Editorial Fellow Rim Abou Chakra and Mariana Carvalho Gouveia discusses the contents of the 2025 August issue of IJGC.
2025-09-0119 minIJGC conversationsIJGC EiC Summer Podcasts: HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial) with Anna FagottiIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anna Fagotti to discuss HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial).
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.
2025-08-2531 minIJGC conversationsIJGC EiC Summer Podcasts: ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. ReynoldsIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .
Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023, she was a Visiting Research Fellow at Mayo Clinic (Rochester, MN, USA), leading projects on AI, the microbiome, and ctDNA in endometrial cancer. She is currently a consultant in the Gynecologic Oncology U...
2025-08-1824 minIJGC conversationsIJGC EiC Summer Podcasts: MIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie PlanteIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss minimally invasive surgery in simple hysterectomy from the subanalysis of SHAPE trial.
Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important international trials, the SHAPE trial and the Contessa trial.
2025-08-1128 minIJGC conversationsImpact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra MartinezIn this IJGC podcast, Dr. Pedro Ramirez discusses Impact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra Martinez.
Martina Angeles is a gynecologic oncology specialist at Vall d’Hebron University Hospital in Barcelona. She trained in Obstetrics and Gynecology at Hospital Clínic de Barcelona and completed an ESGO-accredited fellowship in gynecologic oncology (2018–2020). In 2023, she earned her PhD from the Autonomous University of Madrid, focusing on the role of surgery in advanced ovarian cancer. She is an Editorial Board Member of the IJGC and former ENYGO–IJGC Editorial Fellow. Her main researc...
2025-08-0432 minIJGC conversationsImpact of RCTs on Clinical Practice with Floriane JochumIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Impact of RCTs on Clinical Practice.
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials.
2025-07-2830 minIJGC conversationsLymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios NasioudisIn this IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez discusses Lymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios Nasioudis.
Elizabeth Tubridy is a 3rd year Gynecologic Oncology Fellow at the Hospital of the University of Pennsylvania. She received her Bachelor of Science from Georgetown University and obtained her medical degree from Albert Einstein College of Medicine. She completed her Obstetrics and Gynecology residency at New York University Medical Center. Upon graduation she will be joining the Gynecologic Oncology practice at White Plains Hospital in New York. Her research focuses include the role of tumor in...
2025-07-2128 minIJGC conversationsIJGC conversations 2025 July Editor's Choice
In this episode of the IJGC conversations 2025 July Editor's Choice, Editorial Fellow Helena Obermair and Friederike Stroisch discusses the contents of the 2025 July issue of IJGC.
2025-07-1713 minIJGC conversationsctDNA in Ovarian Cancer with Henri AzaïsIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Henri Azaïs to discuss ctDNA in Ovarian Cancer.
Dr. Henri Azaïs is a gynaecological surgeon specialising in the surgical management of gynaecological cancers at the Hôpital Européen Georges Pompidou in Paris - France. His translational research focuses on late-stage ovarian cancer and in particular on the role of circulating tumour DNA in this disease.
2025-07-1426 minIJGC conversations2025 GTD Guidelines with Christianne Lok and Michael SecklIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Christianne Lok and Michael Seckl to discuss 2025 GTD Guidelines.
Christianne Lok is a leading expert in gynecologic oncology, renowned for her work on cancer diagnosis and treatment during pregnancy as part of the International Network on Cancer, Infertility and Pregnancy (INCIP). She plays a pivotal role in research and clinical guidelines for gestational trophoblastic disease, addressing both medical and psychosocial dimensions. Her contributions to ovarian cancer research include biomarker studies—particularly on ctDNA and HE4—as well as molecular profiling and bioba...
2025-07-0752 minIJGC conversationsPeritoneal Cytology in Endometrial Cancer with Diletta Fumagalli and Gretchen E. GlaserIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Diletta Fumagalli and Gretchen E. Glaser to discuss Peritoneal Cytology in Endometrial Cancer.
Dr. Diletta Fumagalli, M.D., is a research fellow at the Istituto Europeo di Oncologia (IEO), Milan, Italy. She has completed a research fellowship at Mayo clinic. Her research and clinical interests include innovative methods for early detection of endometrial cancer and the evaluation of nutritional risks in patients with ovarian cancer.
Dr. Gretchen E. Glaser, M.D., is a Gynecologic Oncologist in Mayo Clinic. Dr. Glaser focuses her clinical research in endo...
2025-07-0131 minIJGC conversationsRadiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer with Drs. Agustí and Viveros-CarreñoIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí and David Viveros-Carreño to discuss Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program. Dr. Viveros-Carreño is a Gynecologic Oncologist at Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), and Clínica Uni...
2025-06-2329 minIJGC conversationsIJGC conversations 2025 June Editor's ChoiceIn this episode of the IJGC conversations 2025 June Editor's Choice, Editorial Fellow Louisa Proppe, Sofia Bigardi and Rosanu Nelia Marina discusses the contents of the 2025 June issue of IJGC.
2025-06-2012 minIJGC conversationsctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds.In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .
Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023, she was a Visiting Research Fellow at Mayo Clinic (Rochester, MN, USA), leading projects on AI, the microbiome, and ctDNA in endometrial cancer. She is currently a consultant in the Gynecologic Oncology U...
2025-06-1624 minIJGC conversationsIDEAL Framework: Robotics Innovation and Evaluation with Hani MarcusIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Hani Marcus to discuss the IDEAL Framework. Mr. Marcus is a Consultant Neurosurgeon at the National Hospital for Neurology and Neurosurgery and Honorary Associate Professor at the UCL Queen Square Institute of Neurology.
2025-06-0934 minIJGC conversationsModified Radical Hysterectomy for Stage IB1 Cervical Cancer with Koji MatsuoIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Koji Matsuo to discuss Modified Radical Hysterectomy for Stage IB1 Cervical Cancer.
Dr. Matsuo is a professor in the area of gynecologic oncology. Equally attentive to patient care, he devotes his work to scholarly activity related to patient outcomes, quality improvement, and healthcare service research in gynecologic malignancies.
2025-06-0234 minIJGC conversationsRisk Factor for Unsuccessful SLN Mapping with Félix BoriaIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Félix Boria to discuss the Risk Factor for Unsuccessful SLN Mapping.
Dr. Boria is an attending physician of the gynecologic oncology division at the Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain. He completed his PhD at the Universidad Autónoma de Madrid, where his research focused on PET/CT in advanced ovarian cancer.
2025-05-2628 minIJGC conversationsIJGC conversations 2025 May Editor's ChoiceIn this episode of the IJGC conversations 2025 May Editor's Choice, Editorial Fellow Christian Braun, Julia Gelissen and Kyra Fischer discusses the contents of the 2025 May issue of IJGC.
2025-05-2212 minIJGC conversationsSUGAR Initiative: Glycemic control in the perioperative period with Jolyn TaylorIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Jolyn Taylor to discuss SUGAR Initiative: Glycemic control in the perioperative period.
Dr. Taylor is an Associate Professor of Gynecologic Oncology at MD Anderson Cancer Center. She serves as the Associate Chief Quality and Value Officer and the Patient Safety Quality Officer for the Division of Surgery and focuses her research on ways to improve the quality of patient care.
2025-05-1929 minIJGC conversationsHIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial) with Anna FagottiIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anna Fagotti to discuss HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial).
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.
2025-05-1231 minIJGC conversationsMolecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2) with Angeles Alvarez SecordIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr Angeles Alvarez Secord to discuss Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2).
Angeles Alvarez Secord, MD, MHSc, is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Heath System. She received her undergraduate degree with honors from Carroll College in Helena, Montana and graduated AOA with honors from the University of Washington School of Medicine in Seattle, Washington. Dr. Secord completed her residency in obstetrics and gynecology and her fellowship in gynecologic oncology at the...
2025-05-0535 minIJGC conversationsIJGC conversations 2025 April Editor's ChoiceIn this episode of the IJGC conversations 2025 April Editor's Choice, Editorial Fellow Stephanie Gill and Elise Mann Yates discusses the contents of the 2025 April issue of IJGC.
2025-04-3010 minIJGC conversationsReal-word PARPi Maintenance and Recurrence Patterns with Anna Fagotti and Matteo LoverroIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Matteo Loverro and Anna Fagotti to discuss Real-word PARPi Maintenance and Recurrence Patterns.
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.
Matteo Loverro is an ESGO fellow at Fondazione Policlinico Universitario A. Gemelli, IRCCS @unicatt.
2025-04-2941 minIJGC conversationsSubstantial LVSI and Recurrence in Endometrial Cancer with Nadeem Abu-Rustum and Christian DagherIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Nadeem Abu-Rustum and Christian Dagher to discuss Substantial LVSI and Recurrence in Endometrial Cancer.
Dr. Abu-Rustum is a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center. He is also a professor of obstetrics and gynecology at Weill Cornell Medical College. Dr. Abu-Rustum has a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system, and his clinical research focuses on surgical therapy...
2025-04-1428 minIJGC conversationsSurgery for Stage IV Ovarian Cancer with Floriane JochumIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Surgery for Stage IV Ovarian Cancer.
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She recently completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials.
2025-04-0131 minIJGC conversationsRare gynecologic cancers with IJGC fellowsIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by the IJGC editorial fellows to discuss the IJGC Special Issue on Rare gynecologic cancers.
2025-03-2433 minIJGC conversationsQoL Assessment on SHAPE Trial with Sarah E. FergusonIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Sarah E. Ferguson to discuss QoL Assessment on SHAPE Trial.
Dr. Sarah Ferguson is a Gynecologic Oncologist at Princess Margaret Cancer Centre (University Health Network), a Professor and Vice Chair of Research in the Department of Obstetrics and Gynecology at the University of Toronto, and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Ferguson is currently the Head of Research for the Department of Obstetrics and Gynecology for Mount Sinai Hospital/University Health Network. Her clinical and research...
2025-03-1734 minIJGC conversationsDe-escalation in Gynecologic Oncology with Núria AgustíIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí to discuss De-escalation in Gynecologic Oncology. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program
2025-03-1236 minIJGC conversationsIJGC conversations 2025 February Editor's ChoiceIn this episode of the IJGC conversations 2025 February Editor's Choice, Editorial Fellow Matteo Marchetti and Thomas Bartl discusses the contents of the 2025 February issue of IJGC.
2025-03-0210 minIJGC conversationsLANCE Trial: Results of Feasibility Phase with Jose Alejandro Rauh-HainIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jose Alejandro Rauh-Hain to discuss LANCE Trial: Results of Feasibility Phase.
Dr. Rauh-Hain is a Gynecologic Oncologist at the University of Texas MD Anderson Cancer Center. Born in Mexico City, he earned his medical degree from Universidad Panamericana and completed a research fellowship at Massachusetts General Hospital, focusing on preeclampsia biomarkers. He trained in Obstetrics and Gynecology at Massachusetts General and Brigham and Women's Hospital, followed by a Gynecologic Oncology fellowship at Harvard Medical School. He also holds an MPH from Harvard...
2025-02-2536 minIJGC conversationsOvarian cancer risk among older patients with stable adnexal masses with Elizabeth (Betty) Suh-BurgmannIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Elizabeth (Betty) Suh-Burgmann to discuss Ovarian cancer risk among older patients with stable adnexal masses.
Dr. Elizabeth (Betty) Suh-Burgmann, originally from Boulder, Colorado, earned her Bachelor of Arts from Cornell University and completed her medical degree and residency at the University of California, San Francisco. Following a fellowship at Massachusetts General Hospital/Harvard Medical School, she joined Kaiser Permanente in 2000. She is the Chair of Gynecologic Oncology for Kaiser Permanente Northern California, which provides care to approximately 4.4 million patients. She is the...
2025-02-1737 minIJGC conversationsPreoperative Tumor Size and Final Pathology in Cervical Cancer with Teresa PanIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Teresa Pan to discuss Preoperative Tumor Size and Final Pathology in Cervical Cancer. Dr. Teresa Pan is a gynonc doctor in the Innsbruck Medical University, Department of Gynecology and Obstetrics and has an interest in research in cervical cancer.
2025-02-1029 minIJGC conversationsOral Contraceptive Impact on p53 Signatures with Ramlogan SowamberIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Ramlogan Sowamber to discuss Oral Contraceptive Impact on p53 Signatures. Ramlogan Sowamber is a trainee at the University of British Columbia in the department of Medical Genetics, working with Dr. David Huntsman on understanding the impacts of opportunistic salpingectomy on ovarian cancer risk reduction from a genomic and molecular perspective. He is interested in understanding how genetics influences the mechanisms of cancer progression using genomic and functional approaches and how therapeutic interventions can be applied to various cancer subtypes.
2025-02-0343 minIJGC conversationsPRIMA Trial: Overall Survival Results with Antonio González-Martín
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG...
2025-01-2742 minIJGC conversationsGOG3053/ENGOT EN11/KEYNOTE B21:dMMR Outcomes with Brian SlomovitzIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Brian Slomovitz to discuss the dMMR population Outcomes from the GOG3053/ENGOT EN11/KEYNOTE B21. Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies.
2025-01-2030 minIJGC conversationsRecent Trends in Radical Hysterectomy Approach after LACC Trial with Gabriel LevinIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriel Levin to discuss "Recent Trends in Radical Hysterectomy Approach after LACC Trial." Dr. Gabriel Levin is a gynecologic oncology Fellow at McGill University, and an assistant professor at the Hebrew University of Jerusalem. His research encompasses population database studies with clinical implication and innovations in medical education and health care.
2025-01-1332 minIJGC conversationsMIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie Plante
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss minimally invasive surgery in simple hysterectomy from the subanalysis of SHAPE trial.
Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important international trials the SHAPE trial and the Contessa trial.
2025-01-0628 minIJGC conversationsSecondary Cytoreductive Surgery in Endometrial Cancer with Francesco Fanfani
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Francesco Fanfani to discuss secondary cytoreductive surgery in endometrial cancer. Dr. Francesco Fanfani serves as an associate professor in gynecologic oncology at Fondazione Policlinico Universitario Agostino Gemelli, IRCCS in Rome, Italy.
2024-12-1933 min